Zidovudine (AZT) was the first drug approved by the FDA for treatment of HIV infections. To investigate the AZT effects on the physical properties of K562 cell membranes, experiments were performed by measuring an order parameter value in these cells, previously labelled with 16-DSA (16-doxyl-stearic acid) or 5-DSA (5-doxyl-stearic acid). The EPR spectra of the labelled fatty acid were used to detect the alteration in their freedom of motion and to provide indications of membrane fluidity. Two different parameters were calculated from EPR spectra for the 16-DSA and 5-DSA. Preliminary data indicate that, for both the probes used, these parameters were not significantly different in the control cells with respect to the AZT-treated ones. Control measurements, performed to test the sensitivity of the technique using the DMSO agent, showed a significant increase in the K562 membrane fluidity.
Research on Chemical Intermediates – Springer Journals
Published: Oct 13, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera